2025 Outstanding Contribution Award


2025 Outstanding Contribution Award

Jinhe Optoelectronics Branch Company
The person in charge is Chen Fei. Since its establishment in 2012, the branch company has adhered to a business philosophy centered on technological innovation, quality excellence, and management innovation. In the competitive new-energy market, the company has continuously expanded its presence, securing resources from multiple sources and partnering with well-known central state-owned enterprises such as China General Nuclear Power Group, China Energy Engineering Corporation, China Resources, and Tai Fu. The company has successively undertaken the construction of photovoltaic power stations and wind farms in regions including Xinjiang, Inner Mongolia, Qinghai, Gansu, Shandong, Henan, Zhejiang, Yunnan, and Jiangsu, with a total installed capacity exceeding 15,000 MW. Throughout the year, the company achieved a construction output value of 800 million yuan and signed new contracts worth 1.35 billion yuan.

From the fertile lands of Jiangsu and Zhejiang to the black earth of Northeast China, from the mountain city of Chongqing to the loess plateaus of Northwest China, in 2025, Jinhe Optoelectronics firmly commits to the nation’s “Energy Powerhouse” strategy. Partnering with state-owned enterprises and central enterprises, we are showcasing our outstanding optoelectronic prowess and reaping abundant business results. Both construction output value and newly signed contracts have reached new highs, making significant contributions to the Group’s overall scale and serving as a cornerstone for its growth. Moreover, we lead the way in paying group fees, taking the top spot!

lush Sheng International Engineering Branch Company
The person in charge is Yin Weibiao. The branch company focuses exclusively on the foreign-invested sector and, leveraging its professional expertise and strong brand reputation, has achieved remarkable business results. In 2025, it secured nearly ten projects, including those from AstraZeneca Qingdao, Reckitt Shanghai, Johnson & Johnson C8 Suzhou, Merck Nantong, Eli Lilly Suzhou, Genexis Suzhou, Roche Suzhou, Roche Shanghai, Livex Taicang, Qiandao Lake Hangzhou, and Infineon Wuxi. The company’s construction output value reached 650 million yuan, and the value of newly signed contracts totaled 627 million yuan.

Break through challenges with professionalism and earn trust through integrity. Standing firm against the fierce headwinds of the industry, we press forward with the tenacity of “enduring countless trials yet remaining steadfast.” As market competition intensifies, we forge ahead with the determination to “cultivate deeply and steadily move forward,” expanding our footprint in the foreign-invested market. Whether it’s output value or tax contributions, we consistently rank among the top performers within the group. We wish that the banner of “Qi’an Maosheng” will forever fly high in the foreign-invested market!

Recommended news


The Group dispatched representatives to attend the Exchange Meeting on Construction Project Quality and Safety Management and the On-site Observation Session.

In late September, the China Construction Enterprise Management Association organized an experience-sharing and on-site observation conference on quality and safety management in construction projects in Guangzhou, which was attended by representatives from the Group.


Empowering Communities Through Health: Experts Bring Science-Based Education to Qian’an

On September 18, Jiangsu Qian’an Construction Group, in collaboration with the Science Education Base of Qidong People’s Hospital, hosted the 2026 National Science Popularization Event.


Benchmarking against global standards! The Jotun Zhangjiagang project has successfully passed the safety audit conducted by its Norwegian headquarters.

In mid-September, a foreign‑owned expert audit team from Jotun’s Norwegian headquarters conducted a three‑day, headquarter‑level specialized safety audit on the Jotun Zhangjiagang project site undertaken by the Group.


The Roche (Shanghai) project of the Group has successfully achieved 2 million safe man-hours.

On September 17, the Roche (Shanghai) Biopharmaceutical Production Base project, undertaken by the Group, successfully reached the milestone of 2 million safe man-hours.


The Group dispatched personnel to attend the training on building trustworthy quality teams in chemical engineering construction.

On September 16–17, the China Chemical Construction Enterprises Association held a training course on building “Quality‑Trusted Work Teams” in Chengdu, with representatives from the Group in attendance. The session featured a live lecture by Shi Jie, a senior expert of the Association.


Good News Abounds | The Group Has Secured Multiple Emerging Industry Projects in Succession

In the golden autumn season, bountiful harvests abound, and new‑generation growth sectors showcase their strength. Since August, leveraging its deep-rooted expertise and core competencies in industrial installation, the Group has successively won bids for five key projects in emerging productivity fields, with a total contract value exceeding RMB 250 million, injecting robust momentum into its resilient year‑end performance.